News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

What Patients With AML Need to Know About Azacitidine and Venclexta

ByDr. Daniel Peters

December 5th 2025

lung cancer image

Understanding Squamous Cell Lung Cancer and Common Treatment Paths

BySpencer Feldman

December 4th 2025

Image of man.

What Patients Should Know About EGFR Mutated Lung Cancer Treatment

ByDr. Girindra Raval

December 4th 2025

Image of woman.

What Fatigue Feels Like for a Patient With Polycythemia Vera

December 3rd 2025

Every FDA Oncology Approval From November 2025

December 3rd 2025

Trending on CURE

FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma

Every FDA Oncology Approval From November 2025

What Patients Should Know About EGFR Mutated Lung Cancer Treatment

11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection

Finding Support When People Say Others Have It Worse

© 2025 MJH Life Sciences^®

All rights reserved.